Bioventus Inc (BVS) stock news · P/E 17, rev $568.1M
Bioventus Inc (BVS) is a medical devices company listed on US.
This BVS news page leads with what Bioventus Inc filed — not a scraped headline mill.
No cached 8-K sentence for BVS yet. We will not pad this page with generic market recap.
Latest reported BVS revenue for 2025-12-31 was $568.1M. Net income was $22.7M. Revenue was down 0.9% from 2024-12-31 to 2025-12-31. BVS currently screens at market cap $495.1M and trailing P/E 17.1.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BVS stock page; for the tape open the quote page.
BVS stock news FAQ
What are BVS's latest revenue and net income?
Latest cached Bioventus Inc (BVS) revenue for Dec 31, 2025 was $568.1M. Net income was $22.7M. Statements: https://lician.com/financials/bvs
How did BVS revenue change from the prior cached period?
Cached Bioventus Inc (BVS) revenue was down 0.9% from $573.3M (Dec 31, 2024) to $568.1M (Dec 31, 2025). Statements: https://lician.com/financials/bvs
What is BVS's P/E ratio?
Bioventus Inc (BVS) trailing P/E is 17.1 on the latest cached fundamentals snapshot.
What is BVS's market cap?
Bioventus Inc (BVS) market cap is $495.1M on the latest cached fundamentals snapshot.
What kind of company is BVS?
Bioventus Inc (BVS) is a medical devices company listed on US.
Where is BVS stock news listed?
Cached stock news for Bioventus Inc (BVS) is listed at https://lician.com/news/bvs. Filings: https://lician.com/sec/bvs
Not investment advice.